Chris Brawley

5.2k citations
24 papers · 3.7k · 4 hit papers · h-index 15

Impact in

Papers in

Chris Brawley

23 papers receiving 3.7k citations

Chris Brawley's Hit Papers

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. 2022 · 239 citations
2390+3+6Years since publication4008001.2k

Peers

Chris Brawley
Comparison fields: 5 of 68
  • Pulmonary and Respiratory Medicine 3.0k
  • Cancer Research 600
  • Radiology, Nuclear Medicine and Imaging 542
  • Oncology 400
  • Endocrinology, Diabetes and Metabolism 231
Replace Clare Gilson with:
Clare Gilson United Kingdom
Robin Millman United Kingdom
Narayanan Nair Srihari United Kingdom
Anjali M Zarkar United Kingdom
Joanna Gale United Kingdom
Shaun P. Tolan United Kingdom
Fiona McKinna United Kingdom
Angus Robinson United Kingdom
James Pinson Wylie United Kingdom
igor Latorzeff France
Chris Brawley relative to Clare Gilson United Kingdom Clare Gilson's profile →
Citations per field
00.5×1.5×
Clare Gilson · 1×
Citations per year

Countries citing papers authored by Chris Brawley

Since Specialization
Citations

This map shows the geographic impact of Chris Brawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Brawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Brawley more than expected).

Fields of papers citing papers by Chris Brawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Brawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Brawley. The network helps show where Chris Brawley may publish in the future.

Co-authors

The 25 scholars most cited alongside Chris Brawley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chris Brawley Line = papers co-authored together Chris Brawley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Hit paper breakdown →
20171350
2
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Hit paper breakdown →
2018910
3
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
Hit paper breakdown →
2019313
4 2020254
5
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Hit paper breakdown →
2022239
6 2019167
7 2021102
8 202279
9 202370
10 202264
11 202441
12 202032
13 202426
14 202221
15 202217
16 202515
17 202012
18 202211
19 20199
20 20235

About Chris Brawley

Chris Brawley is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Hematology, Radiation and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 3.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer, Lipids, and Metabolism (3 papers), Advanced Radiotherapy Techniques (2 papers), Protein Degradation and Inhibitors (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Cancer Research (600 citations), Radiology, Nuclear Medicine and Imaging (542 citations), Oncology (400 citations) and Endocrinology, Diabetes and Metabolism (231 citations). Chris Brawley has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Mahesh Parmar, Matthew Robert Sydes, Chris C. Parker, Adrian David Cook, Meryem Brihoum, Maria Pearse, Silvia Forcat, igor Latorzeff, Pierre M. Richaud and Carol Fraser‐Browne. Their work appears in journals such as Annals of Oncology, The Lancet, Cell, HemaSphere and European Urology Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact